Biotech Breakout Highlights Flawed ETF Thinking

After a shallow, and it should be emphasized it was quite shallow, pullback last month, the biotechnology sector is flexing its muscles once again. The other thing that is shallow is how many folks, including professional investors, view the biotech sector by way of ETFs. There is ample talk of the sector